NNOCF: AI 评分 48/100 — AI 分析 (4月 2026)
Nanoco Group plc researches, develops, manufactures, and licenses nanomaterials for commercial applications. The company's quantum dots are used in displays, sensors, and medical applications across multiple international markets.
公司概况
概要:
NNOCF是做什么的?
NNOCF的投资论点是什么?
NNOCF在哪个行业运营?
NNOCF有哪些增长机遇?
- Expansion in Display Technology: Nanoco can capitalize on the growing demand for quantum dot displays in TVs, monitors, and mobile devices. The quantum dot display market is projected to reach $34.1 billion by 2028. Nanoco's CFQD quantum dots offer superior color performance and energy efficiency, providing a competitive advantage. Timeline: Ongoing.
- Sensor Applications: The market for quantum dot-based sensors is expanding, driven by applications in environmental monitoring, industrial automation, and medical diagnostics. The global sensor market is expected to reach $278.7 billion by 2029. Nanoco's HEATWAVE quantum dots can be used to develop highly sensitive and accurate sensors. Timeline: Ongoing.
- Medical Imaging: Nanoco's VIVODOTS nanoparticles have potential applications in medical imaging and diagnostics. The medical imaging market is projected to reach $52.98 billion by 2029. These nanoparticles can be used to enhance the contrast and resolution of medical images, improving diagnostic accuracy. Timeline: Ongoing.
- Licensing Agreements: Nanoco can generate revenue through licensing its quantum dot technology to display manufacturers, sensor developers, and medical device companies. Licensing agreements provide a recurring revenue stream and allow Nanoco to expand its market reach without significant capital investment. Timeline: Ongoing.
- Strategic Partnerships: Collaborating with leading technology companies can accelerate the adoption of Nanoco's quantum dot technology. Strategic partnerships can provide access to new markets, distribution channels, and technical expertise. Forming alliances with key players in the display, sensor, and medical industries can enhance Nanoco's competitive position. Timeline: Ongoing.
- Market capitalization of $0.01 billion, reflecting its small-cap status.
- Negative P/E ratio of -4.83, indicating current losses.
- Gross margin of 73.9%, showcasing strong pricing power in its niche market.
- Profit margin of -28.8%, highlighting the need for improved operational efficiency.
- Beta of -0.01, suggesting low volatility compared to the market.
NNOCF提供哪些产品和服务?
- Researches and develops novel nanomaterials.
- Manufactures CFQD quantum dots for display applications.
- Produces HEATWAVE quantum dots for sensor technology.
- Creates VIVODOTS nanoparticles for medical and veterinary uses.
- Licenses its nanomaterial technology to various industries.
- Operates in the United Kingdom, Japan, Singapore, and other international markets.
NNOCF如何赚钱?
- Develops and manufactures quantum dots and other nanomaterials.
- Licenses its technology to companies in the display, sensor, and medical industries.
- Generates revenue through licensing fees and material sales.
- Display manufacturers seeking to improve color performance and energy efficiency.
- Sensor developers requiring highly sensitive and accurate sensing materials.
- Medical device companies looking to enhance medical imaging and diagnostics.
- Security companies using quantum dots for tagging and anti-counterfeiting measures.
- Proprietary technology in quantum dot development and manufacturing.
- Strong patent portfolio protecting its nanomaterial innovations.
- Established relationships with key players in the display and sensor industries.
什么因素可能推动NNOCF股价上涨?
- Upcoming: Potential new licensing agreements for CFQD quantum dots in display applications.
- Ongoing: Expansion of HEATWAVE quantum dots in sensor technology market.
- Ongoing: Development of VIVODOTS nanoparticles for medical imaging.
- Ongoing: Strategic partnerships with leading technology companies to enhance market reach.
NNOCF的主要风险是什么?
- Potential: Competition from established nanomaterial companies.
- Potential: Technological obsolescence in the rapidly evolving semiconductor industry.
- Ongoing: Negative profitability and reliance on licensing agreements for revenue.
- Potential: Economic downturns affecting demand for display and sensor products.
NNOCF的核心优势是什么?
- Proprietary quantum dot technology.
- Strong patent portfolio.
- Global presence and operations.
- Diverse applications across multiple industries.
NNOCF的劣势是什么?
- Negative profitability.
- Small market capitalization.
- Reliance on licensing agreements.
- Limited brand recognition.
NNOCF有哪些机遇?
- Expansion in display technology market.
- Growth in sensor applications.
- Development of new medical imaging solutions.
- Strategic partnerships with leading technology companies.
NNOCF面临哪些威胁?
- Competition from established nanomaterial companies.
- Technological obsolescence.
- Economic downturns affecting demand for display and sensor products.
- Regulatory changes impacting the use of nanomaterials.
NNOCF的竞争对手是谁?
- Balyo SA — Robotics and automation solutions. — (BYLTF)
- Garfunkelux Holdi — Unknown differentiation. — (GARLF)
- Graphene Composites Ltd — Focuses on graphene-based composite materials. — (GNCLF)
- Innexio Corp — Specializes in advanced materials and components. — (INXDF)
- Isidore Technologies Inc — Unknown differentiation. — (ISDCF)
Key Metrics
- MoonshotScore: 48/100
Company Profile
- CEO: Liam Frederick Gray
- Headquarters: Runcorn, GB
- Employees: 47
- Founded: 2017
AI Insight
- OTC Tier: OTC Other
- Disclosure Status: Unknown
常见问题
What does Nanoco Group plc do?
Nanoco Group plc specializes in the research, development, manufacture, and licensing of quantum dots and other nanomaterials. These materials are primarily used in display technologies, sensor applications, and medical imaging. The company's business model revolves around creating innovative nanomaterials and licensing these technologies to manufacturers in various industries, generating revenue through licensing fees and material sales. Nanoco operates globally, serving customers in the display, sensor, and medical device markets.
What do analysts say about NNOCF stock?
As of 2026-03-17, there is no readily available analyst consensus on NNOCF stock due to its OTC listing and limited coverage. Key valuation metrics such as P/E ratio (-4.83) and profit margin (-28.8%) reflect the company's current financial challenges. Growth considerations include the potential for increased licensing revenue and expansion into new markets. Investors should conduct their own due diligence and consider the risks associated with OTC stocks before making any investment decisions.
What are the main risks for NNOCF?
The main risks for Nanoco Group plc include competition from established nanomaterial companies, technological obsolescence in the rapidly evolving semiconductor industry, and reliance on licensing agreements for revenue. The company's negative profitability and small market capitalization also pose financial risks. Additionally, as an OTC-listed stock, NNOCF is subject to greater price volatility and liquidity constraints compared to stocks listed on major exchanges. Investors should carefully consider these risks before investing in NNOCF.